Concepedia

Efficacy and Safety of a New Prolonged Release Formulation of Alfuzosin 10 mg Once Daily versus Alfuzosin 2.5 mg Thrice Daily and Placebo in Patients with Symptomatic Benign Prostatic Hyperplasia

Philip Van Kerrebroeck, A Jardin, K.U. Laval, Paul Van Cangh

European Urology · 2000 · 150 citations · 23 references

DOI

Concepts

References

23

The Development of Human Benign Prostatic Hyperplasia with Age

Stephen J. Berry, Donald S. Coffey, Patrick C. Walsh et al. · The Journal of Urology · 1984 · 2.5K citations

, , +9

The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia

Herbert Lepor, William O. Williford, Michael J. Barry et al. · New England Journal of Medicine · 1996 · 799 citations · Full text

, , +15

Benign Prostatic Hyperplasia Specific Health Status Measures in Clinical Research: How Much Change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is Perceptible to Patients?

Michael J. Barry, William O. Williford, Yuchiao Chang et al. · The Journal of Urology · 1995 · 516 citations

, , +8

Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia

Herbert Lepor · Urology · 1998 · 368 citations · Full text

, , +8

Alfuzosin for treatment of benign prostatic hypertrophy

A Jardin, H. Bensadoun, M. C. DELAUCHE‐CAVALLIER et al. · The Lancet · 1991 · 243 citations

, , +7